Rayno Dx and Tools: Update EXAS
Valuation Does Matter If Revenue Growth Slows Last week we posted a YTD summary of our diagnostics and tools focus stocks. Three stocks that are up over one year but have been weak in 2015. We said that revenue guidance and technicals will be important for: Exact Sciences (EXAS), Genomic Health...
SierraSnowBlog: Tiny Bit of Relief Coming Up…Update 2/23 Powder Day
2/23/15 I was at Mammoth Mountain today with light winds, partly sunny, temp in 20s. There was 8-12 in of light powder with great runs off Chairs 1, 2, 3 and 12 in early am. Stay tuned for March forecast. Colder With Some New Cover Even NOAA confirms precipitation and colder weather ahead...
Rayno Dx and Tools: 2015 Q1 Mid Quarter Update-FMI, CSII, HOLX, ALR
Bullish Trend Continues for Mid-Cap Growth Stocks The Life Science Tools and Clinical Diagnostics sector kept pace with major life science ETF performance. Major ETFs (FBT,IBB,XBI) are up about 10% YTD and our top performers are up over 10%. We will provide an update of our Clinical...
Biotech Bull Market: Trends to Watch in 2015 #1
What will it take to drive the biotech sector to new highs? As we approach new highs for the biotech sector in 2015 here are some market trends to watch as the technicals get a little choppy. The next major indicator will be 2015 Q1 earnings. Stay tuned. Momentum of high fliers is broken and...
Rayno Biopharmaceutical Portfolio Performance: Sector is up 80% from 7/1/13 to 2/11/15
Biotech Stocks Up YTD Despite Choppy Tape NASDAQ 4857.61 approaching March 10, 2000 high of 5048.62 IBB at 320.42 up 5.63% YTD and 351% over 10 Years We have updated our post from 7/1/13 on the Rayno Biopharmaceutical Portfolio with re-balancing. We are approaching all time highs touched in...